Nilesh Gupta1,*, Vivek Gupta1,* and Fakhrul Ahsan1
1School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA *Equal Contribution nilesh.gupta@ttuhsc.edu Phone: 806-356-4015x233
VIEW WEBCAST
Summary
This study tests the efficacy of inhalable liposomes of fasudil, a novel Rho-kinase inhibitor, in providing sustained pulmonary vasodilation in monocrotaline induced rat model of pulmonary arterial hypertension (PAH), thus eliminating the need for multiple dosing. The results indicated that a single administration of inhalable liposomes produced a significant decrease in mean pulmonary arterial pressure (MPAP) for up to 3 hrs, while keeping the systemic pressure in the normal range.